Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Page 1
Application of magnetic particle imaging to evaluate nanoparticle fate in rodent joints.
J Control Release. 2023 Apr;356:347-359. doi: 10.1016/j.jconrel.2023.02.038. Epub 2023 Mar 10.
J Control Release. 2023.
PMID: 36868518
Currently, fluorescence imaging is often used to track nanoparticle fate in animal models; however, this approach has limitations that impede long-term quantitative assessment of nanoparticles over time. The goal of this work was to evaluate an emerging imaging modality, m …
Currently, fluorescence imaging is often used to track nanoparticle fate in animal models; however, this approach has limitations that imped …
Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial.
de Latour RP, Szer J, Weitz IC, Röth A, Höchsmann B, Panse J, Usuki K, Griffin M, Kiladjian JJ, de Castro CM, Nishimori H, Ajayi T, Al-Adhami M, Deschatelets P, Francois C, Grossi F, Risitano AM, Hillmen P.
de Latour RP, et al. Among authors: ajayi t.
Lancet Haematol. 2022 Sep;9(9):e648-e659. doi: 10.1016/S2352-3026(22)00210-1.
Lancet Haematol. 2022.
PMID: 36055332
Clinical Trial.
BACKGROUND: In the PEGASUS trial, the complement C3 inhibitor, pegcetacoplan, showed superiority to eculizumab in improving haematological outcomes in adult patients with paroxysmal nocturnal haemoglobinuria and suboptimal response to eculizumab at 16 weeks. The aim of the open-l …
BACKGROUND: In the PEGASUS trial, the complement C3 inhibitor, pegcetacoplan, showed superiority to eculizumab in improving haematological o …
Item in Clipboard
Direct-Acting Antiviral Therapy for Chronic HCV Infection Results in Liver Stiffness Regression Over 12 Months Post-treatment.
Chan J, Gogela N, Zheng H, Lammert S, Ajayi T, Fricker Z, Kim AY, Robbins GK, Chung RT.
Chan J, et al. Among authors: ajayi t.
Dig Dis Sci. 2018 Feb;63(2):486-492. doi: 10.1007/s10620-017-4749-x. Epub 2017 Sep 8.
Dig Dis Sci. 2018.
PMID: 28887750
BACKGROUND: Liver fibrosis stage determines risk of morbidity and mortality from chronic hepatitis C virus (HCV) infection. Prior data have shown long-term reversal of liver fibrosis, measured by vibration-controlled transient elastography (VCTE), in patients successfully …
BACKGROUND: Liver fibrosis stage determines risk of morbidity and mortality from chronic hepatitis C virus (HCV) infection. Prior data have …
Item in Clipboard
Urinary tract infection in older adults in long-term care facilities.
Ajayi T, Radhakrishnan R.
Ajayi T, et al.
CMAJ. 2016 Sep 6;188(12):899. doi: 10.1503/cmaj.150708. Epub 2016 Feb 1.
CMAJ. 2016.
PMID: 26833739
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite